Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome

Neurology

Prevalence

700.0 / 100K

Incidence

48.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome?

There are 1 clinical trial targeting Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome tracked by BioSniper.

What is the prevalence of Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome?

The estimated prevalence of Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome is approximately 700.0 per 100,000 population.

Deep-dive into Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome — Drugs in Development & Clinical Trials | BioSniper